Staloral

Package leaflet: Information for the patient

STALORAL Plant-derived allergen extracts
STALORAL Animal-derived allergen extracts
STALORAL House dust mite allergen extracts
STALORAL Fungal allergen extracts (moulds, dermatophytes, yeasts)
STALORAL Mixed allergen extracts (plant, animal, mite, fungal)
Oral and sublingual solution
10; 100 IR/ml or 10; 100 IC/ml
Please read all of this leaflet carefully before using this medicine, because it contains
important information for you.

• Keep this leaflet so that you can read it again if necessary.
• If you have any questions, please consult your doctor, pharmacist, or nurse.
• This medicine has been prescribed for a specific individual. Do not pass it on to others. It may harm someone else, even if their symptoms are the same.
• If you experience any adverse reactions, including any not listed in this leaflet, inform your doctor, pharmacist, or nurse. See section 4.

Table of contents

1. What STALORAL is and what it is used for
2. Important information before taking STALORAL
3. How to take STALORAL
4. Possible side effects
5. How to store STALORAL
6. Contents of the pack and other information

1. What STALORAL is and what it is used for

STALORAL is a medicinal product used for specific immunotherapy in patients allergic to plant-derived allergens (pollens), animal-derived allergens, house dust mites, or fungi. A complete list of allergens is provided in Annex 1 attached to this leaflet.
Indications
Allergic diseases with seasonal or perennial symptoms, including rhinitis (sneezing, runny or itchy nose, nasal congestion), conjunctivitis (itchy, watery eyes), or asthma (mild or moderate), in adults and children (over 5 years of age).
The aim of treatment with STALORAL is to increase immunological tolerance to allergens, thereby reducing allergic reactions.

2. Important information before using the medicinal product STALORAL

When not to use STALORAL

• if the patient has a known hypersensitivity (allergy) to any of the other components of this medicinal product (listed in section 6);
• if the patient has immunological disorders or diseases of the immune system;
• if the patient has a malignant (cancerous) disease;
• if the patient has severe or uncontrolled asthma;
• if the patient has oral cavity inflammation.

Only a physician can determine whether contraindications to the use of this medicinal product exist.
Warnings and precautions
Before starting treatment, allergic symptoms should be stabilized with appropriate symptomatic treatment, if necessary.
Before starting treatment with STALORAL, inform your doctor or pharmacist:

• if the patient is experiencing severe clinical symptoms of allergy at the time treatment is to begin – in such cases, treatment should be postponed;
• if the patient has recently suffered from other illnesses or if allergy symptoms have recently worsened;
• if the patient is scheduled for oral surgery or tooth extraction. Treatment with STALORAL should be interrupted until the oral cavity has completely healed;
• if the patient has or has previously had eosinophilic esophagitis;
• if during treatment the patient experiences severe or persistent abdominal pain, difficulty swallowing, or chest pain;
• if the patient is on a strict low-sodium diet, as this medicinal product contains sodium (see section "STALORAL contains sodium chloride");
• if the patient is taking beta-adrenergic blocking agents (beta-blockers), including eye drops or topical creams.

Interaction of STALORAL with other medicinal products
Inform your doctor about all medicinal products you are currently taking, including those available without a prescription.
Before starting treatment, inform your doctor:

• if the patient is taking certain antidepressant medications (tricyclic antidepressants or monoamine oxidase inhibitors - MAOIs), as there is an increased risk of adverse effects if epinephrine (used in severe allergic reactions) needs to be administered, potentially with fatal outcome;
• if the patient is scheduled for prophylactic vaccination against infectious diseases. Vaccination may be performed without interrupting treatment, but only after assessment of the patient's general health status.

Symptomatic treatment (e.g. with antihistamines and/or intranasal corticosteroids) may be used concomitantly with STALORAL.
Pregnancy and breastfeeding
Female patients who are pregnant, suspect they may be pregnant, or plan to become pregnant should consult their doctor or pharmacist before using this medicinal product.
Female patients who are breastfeeding should consult their doctor or pharmacist before using this medicinal product.
There is no experience regarding the use of STALORAL during pregnancy or breastfeeding; therefore, immunotherapy should not be initiated in pregnant or breastfeeding women unless considered necessary by the physician.
Female patients who become pregnant or start breastfeeding during treatment with this medicinal product should consult their doctor regarding continuation of treatment.
Driving and operating machinery
There are no contraindications to driving or operating machinery during treatment with STALORAL.
STALORAL contains sodium chloride
In patients on a low-sodium diet, the presence of sodium chloride in the product should be taken into account (one vial, i.e. 10 ml of solution, contains 590 mg of sodium chloride). See section "Warnings and precautions".

3. How to use STALORAL

This medicine should always be used exactly as directed by the physician. In case of doubt, consult
your doctor or pharmacist.
Specific immunotherapy is most effective when started in the early phase of the disease.
The dose size does not depend on age, but on the individual reactivity of the patient.
In seasonal allergy, treatment should be initiated before the pollen season and continued until
the end of the pollen season.
In perennial allergy, treatment should be continued throughout the entire year.
Treatment consists of two phases:

• initial treatment – with gradually increasing dose
• maintenance treatment – with a constant dose.

Before each administration, carefully check the information on the packaging and ensure that the details
match the physician's prescription: composition and concentration of the medicine, and verify the expiry date.
Initial treatment with dose escalation
The medicine is taken daily, increasing the dose each day until reaching the maintenance dose according to the
following scheme:
The above dosing schedule should be considered as a guideline and example of treatment. The treatment may be
modified depending on the patient's condition and response to therapy.
Maintenance treatment – constant dose
The maximum, well-tolerated dose should be taken daily or three times per week.
Duration of treatment
Desensitizing treatment is generally administered for 3 to 5 years.
The physician will re-evaluate the treatment if there is no significant improvement in symptoms after one year (in
perennial allergy) or after the first pollen season (in seasonal allergy).
Method of administration
To ensure safe use of the medicine, strictly follow the physician's instructions.
STALORAL is administered sublingually.
The medicine should be taken during the day into an empty mouth, without eating or drinking.
Before each use, check the expiry date and confirm that the vial used corresponds to the physician's prescription.
Use the dosing pump mechanism to administer the appropriate amount of solution directly into the oral cavity under
the tongue.
Wait 2 minutes before swallowing the solution.
The physician may recommend a different dosing schedule depending on the patient's condition and response to
treatment.
STALORAL should be administered to children by adults.
Information regarding first-time use:
For safety reasons and to ensure the vial remains intact, vials are hermetically sealed with a plastic and aluminium
cap.
Always verify that the medicine corresponds to the one prescribed by the physician. In case of doubt, consult your
doctor.
It is extremely important to read carefully the instructions for using the dosing pump. If necessary, ask your doctor
for detailed clarification.

For the first-time use, follow the steps below:

1. Remove the coloured plastic part of the cap.
2. Pull the metal tear-strip and completely remove the aluminium cap.
3. Remove the grey stopper.
4. Remove the dosing pump from its plastic protective sleeve. Place the vial on a flat surface and, holding it firmly with one hand, press the pump firmly into place.
5. Remove the purple protective ring.
6. Prime the pump by pressing the pump plunger five times. Discard the solution that comes out. The dosing pump will deliver one full dose of medicine only after five actuations.
7. Place the tip of the dosing pump into the mouth, directly under the tongue.
8. Press the pump plunger steadily until it stops. Use the finger that can apply the strongest pressure.
9. Release the pump plunger completely. Ensure that at least a 2-second interval is maintained between each actuation.
10. Repeat the above procedure until the number of actuations prescribed by the physician is reached. Hold the solution under the tongue for 2 minutes, then swallow.
11. After use, clean the tip of the dosing pump and replace the protective ring.

For subsequent uses, remove the protective ring and repeat the steps starting from point 7.
Use in children
Allergen immunotherapy is not recommended for children under 5 years of age.
Use of a higher than recommended dose of STALORAL
Inform your doctor or pharmacist immediately.
If a higher than recommended dose is used, the risk of adverse reactions increases, including systemic reactions or
severe local reactions.
Missed dose of STALORAL
It is recommended to take the medicine at the usual dose the following day.
Do not take a double dose to make up for a missed dose.
If several consecutive doses are missed, contact the doctor who prescribed the treatment to establish a new
treatment schedule.
Discontinuation of STALORAL treatment
If STALORAL treatment is interrupted for less than one week, continue treatment using the last dose. If treatment is
interrupted for more than one week, contact your doctor.
If you have any further doubts regarding the use of this medicine, consult your doctor, pharmacist, or nurse.

4. Possible adverse reactions

Like any medicine, this medicine may cause adverse reactions, although not everyone experiences them.
During treatment with STALORAL, the patient will be exposed to substances which may
cause allergic reactions at the site of administration and/or symptoms which may affect the
whole body.
Such reactions may occur at the beginning of treatment or later, during treatment.
STALORAL must be discontinued immediately and medical help sought if any of the following
symptoms occur or are observed:
Severe allergic reaction with rapid onset of symptoms affecting the whole body, such as
intense itching or rash, difficulty breathing, abdominal pain, or symptoms related to
low blood pressure such as dizziness and feeling unwell.
Tolerance to a given dose may change over time depending on the patient's health status and environment.
If an adverse reaction occurs, consult a physician, who may modify the treatment regimen.
The physician may prescribe pre-treatment with antiallergic medications to reduce the frequency and severity of adverse reactions.
The following additional adverse reactions have also been observed:
Common (affects less than 1 in 10 patients)
Oral cavity disorders (e.g. swelling, discomfort, tingling, itching, numbness, blisters, ulcers), tongue swelling, throat discomfort or pain, or swelling or irritation, rhinitis (nasal congestion, runny nose, sneezing, itchy nose, nasal discomfort), cough, salivary gland disorders, itchy eyes, itchy ears, nausea, vomiting, abdominal pain, diarrhoea, skin redness or itching.
Uncommon (affects less than 1 in 100 patients)
Eye disorders (redness, eye irritation, watery eyes), herpes, hoarseness, breathing difficulties, asthma, urticaria, atypical skin hypersensitivity symptoms (burning, tingling, pricking), gastritis, oesophageal spasms.
Rare (affects less than 1 in 1000 patients)
Headache, eczema, joint pain, muscle pain, weakness, enlarged lymph nodes, fever.
In addition, the following adverse reactions have been reported:
Taste disturbances, dry mouth sensation, dizziness, facial swelling, severe allergic reactions, oesophagitis.
Reporting of adverse reactions
If any adverse reactions occur, including any adverse reactions not listed in this leaflet, inform your doctor, pharmacist, or nurse. Adverse reactions can be reported directly to the Department of Monitoring Adverse Reactions of Medicinal Products, Office for Registration of Medicinal Products, Medical Devices and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw,
tel. 22 49 21 301
fax. 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Adverse reactions can also be reported to the marketing authorization holder.
Reporting adverse reactions helps to provide more information on the safety of the medicine.

5. How to store STALORAL

Before opening: Store in the refrigerator (2°C - 8°C).
After first opening: Store in the refrigerator (2°C - 8°C) for up to 30 days.
During transport, vials must always be carried in an upright position.
Keep the medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the carton after EXP and for longer than 30 days after first opening. The expiry date refers to the last day of the stated month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Contents of the pack and other information

What STALORAL contains
The active substances are allergen extracts or their mixtures combined with mannitol. The amount of mannitol does not exceed 40 mg/ml.
1 vial (10 ml) of solution contains allergen extracts (according to Annex No. 1) at a concentration of:
10; 100 IR*/ml (standardized allergen extract)
or
10; 100 IC**/ml (non-standardized allergen extract)
The qualitative composition of the active substance may be individually selected for the patient from among the allergens listed in Annex No. 1.
*/**) The activity of the respective allergen expressed in IR/ml or IC/ml units is indicated on the label.

• Other ingredients: sodium chloride, glycerol, purified water.

What STALORAL looks like and contents of the pack
STALORAL is a clear, colourless or yellowish-brown solution, depending on the type and concentration of the allergen.
The starter treatment pack contains:
2 vials of 10 ml each (concentration 10 IR/ml or 10 IC/ml; concentration 100 IR/ml or 100 IC/ml) and 2 dosing pumps.
Blue cap – concentration: 10 IR/ml or 10 IC/ml
Red cap – concentration: 100 IR/ml or 100 IC/ml
The maintenance treatment pack contains:
2 vials of 10 ml each (concentration 100 IR/ml or 100 IC/ml) – red caps.
2 dosing pumps.

Marketing Authorisation Holder and Manufacturer
STALLERGENES
6, rue Alexis de Tocqueville
92160 Antony, France
For further information, please contact the representative of the Marketing Authorisation Holder in Poland:
STALLERGENES Sp. z o.o.
tel. 22 620 29 98

STALORAL ANNEX NO. 1

I. Plant-derived allergen extracts
Weeds
641 Alfalfa (Medicago sativa) IC/ml
664 Common dandelion (Taraxacum vulgare) IC/ml
623 White goosefoot (Chenopodium album) IC/ml
673 Canadian goldenrod (Solidago canadensis) IC/ml
636 Common hop (Humulus lupulus) IC/ml
605 Mugwort (Artemisia vulgaris) IR/ml
646 Black mustard (Brassica nigra) IC/ml
654 Common nettle (Urtica dioica) IC/ml
643 Ox-eye daisy (Chrysanthemum leucanthemum) IC/ml
665 Plantain (Plantago) IC/ml
604 Ragweed (Ambrosia elatior) IR/ml
625 Cabbage (Brassica oleifera) IC/ml
710 Prickly saltwort (Salsola kali) IC/ml
655 Common sorrel (Rumex acetosa) IC/ml
678 Common sunflower (Helianthus annuus) IC/ml
657 Parietaria officinalis (Parietaria officinalis) IR/ml

Grasses
601 Common bent (Agrostis vulgaris) IC/ml
705 Bermuda grass (Cynodon dactylon) IR/ml
627 Timothy grass (Dactylis glomerata) IR/ml
624 Couch grass (Agropyron repens) IC/ml
630 Meadow fescue (Festuca elatior) IC/ml
658 Meadow bluegrass (Poa pratensis) IR/ml
638 Perennial ryegrass (Lolium perenne) IR/ml
631 Sweet vernal grass (Anthoxanthum odoratum) IR/ml
661 Timothy grass (Phleum pratense) IR/ml
637 Velvet grass (Holcus lanatus) IC/ml

Cereals
652 Barley (Hordeum vulgare) IC/ml
642 Maize (Zea mays) IC/ml
610 Oat (Avena sativa) IC/ml
671 Rye (Secale cereale) IR/ml
614 Wheat (Triticum vulgare) IC/ml
106 Wheat flour IC/ml

Trees
609 Black alder (Alnus glutinosa) IR/ml
632 Ash (Fraxinus excelsior) IC/ml
635 European beech (Fagus sylvatica) IC/ml
615 Silver birch (Betula alba) IR/ml
620 Sweet chestnut (Castanea vulgaris) IC/ml
626 Cypress (Cupressus sempervirens) IC/ml
675 Black elder (Sambucus nigra) IC/ml
653 Field elm (Ulmus campestris) IC/ml
667 Black locust (Robinia pseudoacacia) IR/ml
649 Hazel (Corylus avellana) IR/ml
619 Hornbeam (Carpinus betulus) IR/ml
644 Horse chestnut (Aesculus hippocastanum) IC/ml
634 Common juniper (Juniperus communis) IC/ml
677 Large-leaved lime (Tilia platyphyllos) IC/ml
629 Sycamore maple (Acer pseudoplatanus) IC/ml
645 Silver wattle (Acacia dealbata) IC/ml
647 White mulberry (Morus alba) IC/ml
621 Pedunculate oak (Quercus robur) IC/ml
651 Olive (Olea europaea) IR/ml
662 Scots pine (Pinus sylvestris) IC/ml
666 London plane (Platanus vulgaris) IC/ml
659 White poplar (Populus alba) IC/ml
680 Common privet (Ligustrum vulgare) IC/ml
650 Walnut (Juglans regia) IC/ml
669 Goat willow (Salix caprea) IC/ml

Tobacco
904 Tobacco (leaves) IC/ml

II. Animal-derived allergen extracts (fur, epithelia, insects)
Animals
507 Cat IR/ml
509 Dog IC/ml
510 Guinea pig IC/ml
511 Hamster IC/ml
516 Horse IC/ml
512 Rabbit IC/ml
505 Sheep wool IC/ml

Insects
301 Cockroach IC/ml
303 Grain weevil IC/ml
310 Horsefly IC/ml
307 Mosquito IC/ml

III. House dust mite allergen extracts
325 Acarus siro IC/ml
314 Dermatophagoides farinae IR/ml
315 Dermatophagoides pteronyssinus IR/ml
326 Euroglyphus manni IC/ml
324 Glyciphagus domesticus IC/ml
317 Lepidoglyphus destructor IC/ml
318 Tyrophagus putrescentiae IC/ml

IV. Fungal allergen extracts (moulds, yeasts, dermatophytes)
402 Botrytis cinerea IC/ml
403 Candida albicans IC/ml
407 Chaetomium globosum IC/ml
409 Epicoccum IC/ml
410 Epidermophyton IC/ml
411 Fusarium IC/ml
413 Helminthosporium IC/ml
447 Merulius lacrymans IC/ml
417 Mucor racemosus IC/ml
425 Pullularia pullulans IC/ml
426 Rhizopus nigricans IC/ml
432 Stemphylium botryosum IC/ml
435 Trichophyton IC/ml
405 Trichothecium roseum (cephalothecium) IC/ml

V. Mixtures of allergen extracts
* Animal-derived
506 Feather mixture (duck, goose, chicken) IC/ml

* Plant-derived
a) Weeds
719 Mixture I - Compositae (Golden rod, Dandelion, Lampourde, Ox-eye-daisy) IC/ml
714 Mixture II - Chenopodiaceae (Fat hen, Rough pigweed) IC/ml
706 Mixture III - Weed mixtures (Alfalfa, Red clover, Mustard, Nettle, Sorrel) IC/ml

b) Grasses
701 3 grasses - (Timothy grass, Perennial ryegrass, Timothy grass) IR/ml
688 5 grasses - (Timothy grass, Meadow bluegrass, Perennial ryegrass, Sweet vernal grass, Timothy grass) IR/ml
689 12 grasses - (Common bent, Bermuda grass, Bromus, Timothy grass, Meadow fescue, Meadow bluegrass, Oat grass, Perennial ryegrass, Sweet vernal grass, Timothy grass, Wild oat, Velvet grass) IR/ml
690 5 grasses/4 cereals - (Timothy grass, Meadow bluegrass, Perennial ryegrass, Sweet vernal grass, Timothy grass / barley, maize, oat, wheat) IR/ml
687 4 cereals - (barley, maize, oat, wheat) IR/ml

c) Trees
702 Betulaceae (alder, birch, hazel, hornbeam) IR/ml
696 Fagaceae (beech, sweet chestnut, oak) IC/ml
716 Cupressaceae (cypress, juniper) IC/ml
715 Oleaceae (ash, olive, privet) IC/ml
717 Salicaceae (poplar, willow) IC/ml
718 Tree mixture (maple, horse chestnut, plane, black locust, lime) IC/ml
917 Wood dust (oak, beech, cherry, pine) IC/ml

* Mites
350 D. pteronyssinus + D. farinae IR/ml
330 Storage mites (Acarus siro, Glyciphagus domesticus, Lepidoglyphus destructor, Tyrophagus putrescentiae) IC/ml

* Fungi
400 Alternaria (alternata, longipes) IC/ml
414 Cladosporium (cladosporoides, herbarum) IC/ml
401 Aspergillus (fumigatus, nidulans, niger) IC/ml
422 Penicillium (digitatum, expansum, notatum) IC/ml
445 Yeast mixture (Saccharomyces cerevisiae, minor) IC/ml
446 Smut mixture (Ustilago avenae, tritici, holci, zeae) IC/ml